Precigen (NASDAQ:PGEN – Get Free Report) was upgraded by research analysts at StockNews.com to a “sell” rating in a research note issued on Tuesday. Precigen Stock Performance NASDAQ PGEN opened at $1.38 on Tuesday. The company’s fifty day moving average is $1.30 and its two-hundred day moving average is $1.32. Precigen has a 52-week low […]
Related Keywords
United States , Randalj Kirk , , Principal Financial Group Inc , Precigen Inc , Sg Americas Securities , Magnolia Capital Advisors , Sanders Morris Harris , Allspring Global Investments Holdings , Precigen Company Profile , Securities Exchange Commission , Get Free Report , Director Randal , Exchange Commission , Morris Harris , Global Investments Holdings , Financial Group , Capital Advisors , Precigen Daily , Precigen , Nasdaq Pgen , Opgen , Medical , Upgrade , Stocknews Com ,
comparemela.com © 2020. All Rights Reserved.